Covid-19-FDA EUA antigen detection- FDA fast track serology assay optimization
Ended Awarded Last action
- Contract number
- W81XWH20F0253
- Awardee
-
Inbios International Inc. UEI CNJNQ1GMSN55
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $24,533,391
Award facts
- Opportunity
-
- W81XWH15R0014 Solicitation number
- Development of multiple immunochromatographic test (ICTs) for the rapid diagnosis/detection of infectious diseases (IDs), and biological warfare agent (BWA) related IDs of military significance. Award Notice · Posted Nov 20, 2014
- Contract value 96% obligated
- $25,655,995.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Seattle, WA 98109, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $0 | |
| Funding Only Action | -$1,122,604 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $9,779,805 | |
| Supplemental Agreement for work within scope | -$9,779,805 | |
| Supplemental Agreement for work within scope | $420,014 | |
| Funding Only Action | -$420,014 | |
| Funding Only Action | $529,302 | |
| Supplemental Agreement for work within scope | -$529,302 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $1,056,034 | |
| Supplemental Agreement for work within scope | -$1,056,034 | |
| Supplemental Agreement for work within scope | $9,084,116 | |
| Supplemental Agreement for work within scope | $889,899 | |
| Supplemental Agreement for work within scope | -$889,899 | |
| Supplemental Agreement for work within scope | $4,289,036 | |
| Supplemental Agreement for work within scope | $9,804,306 | |
| Original award | $2,478,538 |
Show all 18
About this award
The Defense Health Agency issued a delivery order to Inbios International Inc. on June 15, 2020, with a ceiling value of $25,655,995.03 for COVID-19 FDA EUA antigen detection and fast-track serology assay optimization under a Total Small Business set-aside.
Inbios International Inc. is a minority-owned biotechnology company based in Seattle, Washington. Place of performance is Seattle, WA. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of May 31, 2025. The scope encompasses contractor-acquired property and government-furnished equipment for diagnostic development and production supporting pandemic response.
Quick answers
Who was awarded contract W81XWH20F0253?
W81XWH20F0253 was awarded to Inbios International Inc. by Defense Health Agency (Department of Defense) on June 15, 2020.
How much is contract W81XWH20F0253 worth?
The government has obligated $24,533,391 on W81XWH20F0253. Its current value, with exercised options, is $25,655,995.
Is contract W81XWH20F0253 an order under another contract?
Yes. W81XWH20F0253 is a delivery order under W81XWH16D0009, an indefinite delivery contract.
Was contract W81XWH20F0253 competed?
The extent of competition for W81XWH20F0253 was full and open competition after exclusion of sources. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award